Located in the center of Brisbane, Australia, Resolian Bioanalytics is a newly established and purpose-built bioanalytical laboratory that can provide comprehensive service to support pre-clinical and clinical studies in Australia and worldwide.
Lab Description
Inside the 2,000 square-meter facility, the Brisbane laboratory is equipped with state-of-the-art instrumentation and staffed by a team of seasoned scientists, under the expert management of a group of industry-renowned pioneers. Committed to adhering to the stringent standards of Good Laboratory Practice (GLP), acknowledged and accredited by NATA, Resolian is dedicated to delivering expeditious and top-tier services.
Together with global labs in the US, the UK, Australia, and China, it’s assured that your journey starts with phase I in Australia with Resolian and extends seamlessly across the globe for your subsequent phase II or III trials. Your success is our success, and Resolian is here to make your scientific ambitions a reality.
Resolian Bioanalytics Brisbane 34 Corporate Dr, Cannon Hill QLD 4170, Australia
Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade.
Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia.
Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD.
Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.